This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Presymptomatic gene mutation testing has been available for individuals at risk for hereditary breast and ovarian cancer (HBOC) for 15 years (Miki et al., 1994). This has created a category of individuals with specific genetic mutations who are well but living with knowledge that it is highly probable they will become ill in the future. Little is known about how individuals live with such knowledge beyond the months immediately following testing.
We care about your feedback. Let us know how we can improve your CancerCompass experience.